The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Diabetic retinopathy screening: a systematic review of the economic evidence
Abstract
Diabet. Med. 27, 249–256 (2010) This paper systematically reviews the published literature on the economic evidence of diabetic retinopathy screening. Twenty‐nine electronic databases were searched for studies published between 1998 and 2008. Internet searches were carried out and reference lists of key studies were hand searched for relevant articles. The key search terms used were ‘diabetic retinopathy’, ‘screening’, ‘economic’ and ‘cost’. The search identified 416 papers of which 21 fulfilled the inclusion criteria, comprising nine cost‐effectiveness studies, one cost analysis, one cost‐minimization analysis, four cost–utility analyses and six reviews. Eleven of the included studies used economic modelling techniques and/or computer simulation to assess screening strategies. To date, the economic evaluation literature on diabetic retinopathy screening has focused on four key questions: the overall cost‐effectiveness of ophthalmic care; the cost‐effectiveness of systematic vs. opportunistic screening; how screening should be organized and delivered; and how often people should be screened. Systematic screening for diabetic retinopathy is cost‐effective in terms of sight years preserved compared with no screening. Digital photography with telemedicine links has the potential to deliver cost‐effective, accessible screening to rural, remote and hard‐to‐reach populations. Variation in compliance rates, age of onset of diabetes, glycaemic control and screening sensitivities influence the cost‐effectiveness of screening programmes and are important sources of uncertainty in relation to the issue of optimal screening intervals. There is controversy in relation to the economic evidence on optimal screening intervals. Further research is needed to address the issue of optimal screening interval, the opportunities for targeted screening to reflect relative risk and the effect of different screening intervals on attendance or compliance by patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
The National Institute for Clinical Excellence
(2001) · Nursing Management · doi:10.7748/nm.8.2.39.s15 · Cited by 3,876
Andermann, A. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.050112 · Cited by 903
Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy
Javitt, J. C., & Aiello, L. P. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00017 · Cited by 411
Vijan, S. (2000) · JAMA · doi:10.1001/jama.283.7.889 · Cited by 295
Younis, N., Broadbent, D. M., Vora, J. P., & Harding, S. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12267-2 · Cited by 289
An economic analysis of interventions for diabetes.
Klonoff, D. C., & Schwartz, D. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.390 · Cited by 267
Utility values and diabetic retinopathy
Brown, M. M., Brown, G. C., Sharma, S., & Shah, G. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00146-4 · Cited by 222
Cost-Effectiveness of Strategies for Detecting Diabetic Retinopathy
Dasbach, E. J., Fryback, D. G., Newcomb, P. A., Klein, R., & Klein, B. E. K. (1991) · Medical Care · doi:10.1097/00005650-199101000-00003 · Cited by 184
Cost effectiveness analysis of screening for sight threatening diabetic eye disease
James, M. (2000) · BMJ · doi:10.1136/bmj.320.7250.1627 · Cited by 168
Cited by
Ting, D. S. W., Cheung, G. C. M., & Wong, T. Y. (2016) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.12696 · Cited by 1,066
Guidelines on Diabetic Eye Care
Wong, T. Y., Sun, J., Kawasaki, R., Ruamviboonsuk, P., Gupta, N., Lansingh, V. C., Maia, M., Mathenge, W., Moreker, S., Muqit, M. M. K., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.04.007 · Cited by 839
The pathology associated with diabetic retinopathy
Lechner, J., O'Leary, O. E., & Stitt, A. W. (2017) · Vision Research · doi:10.1016/j.visres.2017.04.003 · Cited by 474
Song, P., Yu, J., Chan, K. Y., Theodoratou, E., & Rudan, I. (2018) · Journal of Global Health · doi:10.7189/jogh.08.010803 · Cited by 341
Recent directions in telemedicine: Review of trends in research and practice
Wilson, L. S., & Maeder, A. J. (2015) · Healthcare Informatics Research · doi:10.4258/hir.2015.21.4.213 · Cited by 203
Metadata
- Authors
- Jones, S., & Edwards, R. T.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2010-03
- Volume
- 27
- Issue
- 3
- Pages
- 249-256
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2142914838
- Cited by
- 265
- References
- 24
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetic retinopathy screening: a systematic review of the economic evidence. https://app.cochat.ai/papers/10.1111/j.1464-5491.2009.02870.x
- The paper
- Jones, S., & Edwards, R. T. (2010). Diabetic retinopathy screening: a systematic review of the economic evidence. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2009.02870.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.